These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 8577054)
1. [I-cell disease and pseudo-Hurler polydystrophy]. Owada M Nihon Rinsho; 1995 Dec; 53(12):3028-34. PubMed ID: 8577054 [TBL] [Abstract][Full Text] [Related]
2. Fibroblasts from patients with I-cell disease and pseudo-Hurler polydystrophy are deficient in uridine 5'-diphosphate-N-acetylglucosamine: glycoprotein N-acetylglucosaminylphosphotransferase activity. Reitman ML; Varki A; Kornfeld S J Clin Invest; 1981 May; 67(5):1574-9. PubMed ID: 6262380 [TBL] [Abstract][Full Text] [Related]
3. Plasma hyaluronidase activity in mucolipidoses II and III: marked differences from other lysosomal enzymes. Natowicz MR; Wang Y Am J Med Genet; 1996 Oct; 65(3):209-12. PubMed ID: 9240745 [TBL] [Abstract][Full Text] [Related]
4. Identification of a variant of mucolipidosis III (pseudo-Hurler polydystrophy): a catalytically active N-acetylglucosaminylphosphotransferase that fails to phosphorylate lysosomal enzymes. Varki AP; Reitman ML; Kornfeld S Proc Natl Acad Sci U S A; 1981 Dec; 78(12):7773-7. PubMed ID: 6461005 [TBL] [Abstract][Full Text] [Related]
5. [Disorders of phosphorylation system of lysosomal enzymes [mucolipidosis II, III]]. Owada M Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):469-73. PubMed ID: 9645113 [No Abstract] [Full Text] [Related]
6. Correction of mucolipidosis III in vitro by gene transfer. Fowler ML; Fan YS; Mueller OT; Henry WM; Shows TB Genomics; 1993 Nov; 18(2):236-43. PubMed ID: 8288225 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of mouse GlcNAc-1-phosphotransferase-gamma subunit in cells induced an I-cell-like phenotype of mucolipidosis. Sun Q; Li J; Wang C; Huang X; Huang H; Du D; Liang Y; Han H Gene; 2005 Feb; 347(1):55-64. PubMed ID: 15716021 [TBL] [Abstract][Full Text] [Related]
8. Mucolipidosis II (I-cell disease) and mucolipidosis IIIA (classical pseudo-hurler polydystrophy) are caused by mutations in the GlcNAc-phosphotransferase alpha / beta -subunits precursor gene. Kudo M; Brem MS; Canfield WM Am J Hum Genet; 2006 Mar; 78(3):451-63. PubMed ID: 16465621 [TBL] [Abstract][Full Text] [Related]
9. Lysosomal phospholipase activity is decreased in mucolipidosis II and III fibroblasts. Jansen SM; Groener JE; Poorthuis BJ Biochim Biophys Acta; 1999 Jan; 1436(3):363-9. PubMed ID: 9989267 [TBL] [Abstract][Full Text] [Related]
10. Mucolipidosis II and III. The genetic relationships between two disorders of lysosomal enzyme biosynthesis. Mueller OT; Honey NK; Little LE; Miller AL; Shows TB J Clin Invest; 1983 Sep; 72(3):1016-23. PubMed ID: 6309902 [TBL] [Abstract][Full Text] [Related]
11. [Lysosomal hydrolases have specific conformational domains for acquisition of mannose-6-phosphate]. Himeno M; Tanaka Y Nihon Rinsho; 1995 Dec; 53(12):2892-7. PubMed ID: 8577031 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the mutant N-acetylglucosaminylphosphotransferase in I-cell disease and pseudo-Hurler polydystrophy: complementation analysis and kinetic studies. Ben-Yoseph Y; Pack BA; Mitchell DA; Elwell DG; Potier M; Melançon SB; Nadler HL Enzyme; 1986; 35(2):106-16. PubMed ID: 3017692 [TBL] [Abstract][Full Text] [Related]
14. A novel mutation in UDP-N-acetylglucosamine-1-phosphotransferase gamma subunit (GNPTAG) in two siblings with mucolipidosis type III alters a used glycosylation site. Tiede S; Cantz M; Raas-Rothschild A; Muschol N; Bürger F; Ullrich K; Braulke T Hum Mutat; 2004 Dec; 24(6):535. PubMed ID: 15532026 [TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of the GNPTAB and GNPTG genes in 13 patients with mucolipidosis type II or type III - identification of eight novel mutations. Encarnação M; Lacerda L; Costa R; Prata MJ; Coutinho MF; Ribeiro H; Lopes L; Pineda M; Ignatius J; Galvez H; Mustonen A; Vieira P; Lima MR; Alves S Clin Genet; 2009 Jul; 76(1):76-84. PubMed ID: 19659762 [TBL] [Abstract][Full Text] [Related]
16. Steps in the phosphorylation of the high mannose oligosaccharides of lysosomal enzymes. Kornfeld S; Reitman ML; Varki A; Goldberg D; Gabel CA Ciba Found Symp; 1982; (92):138-56. PubMed ID: 6295719 [TBL] [Abstract][Full Text] [Related]
17. Altered molecular size of N-acetylglucosamine 1-phosphotransferase in I-cell disease and pseudo-Hurler polydystrophy. Ben-Yoseph Y; Potier M; Mitchell DA; Pack BA; Melançon SB; Nadler HL Biochem J; 1987 Dec; 248(3):697-701. PubMed ID: 2829837 [TBL] [Abstract][Full Text] [Related]
18. Targeting of lysosomal enzymes: N-acetylglucosamine-1-phosphotransferase during muscle development. Den H; Shanske S; DiMauro S Muscle Nerve; 1986; 9(3):261-4. PubMed ID: 3010102 [TBL] [Abstract][Full Text] [Related]
19. Lysosomal enzyme phosphorylation in human fibroblasts. Kinetic parameters offer a biochemical rationale for two distinct defects in the uridine diphospho-N-acetylglucosamine:lysosomal enzyme precursor N-acetylglucosamine-1-phosphotransferase. Lang L; Takahashi T; Tang J; Kornfeld S J Clin Invest; 1985 Dec; 76(6):2191-5. PubMed ID: 3001146 [TBL] [Abstract][Full Text] [Related]
20. Demonstration of the heterozygous state for I-cell disease and pseudo-Hurler polydystrophy by assay of N-acetylglucosaminylphosphotransferase in white blood cells and fibroblasts. Varki A; Reitman ML; Vannier A; Kornfeld S; Grubb JH; Sly WS Am J Hum Genet; 1982 Sep; 34(5):717-29. PubMed ID: 6289658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]